Community social vulnerability and access to medications for opioid use disorder within the continental US: A cross-sectional study

Autor: Paykin S, Emily A. Wang, Joudrey Pj, Marynia Kolak, Lin Q, Anguiano

The COVID-19 pandemic, like past natural disasters, was associated with significant disruptions in medications for opioid use disorder services and increased opioid overdose and mortality. We examined the association between community vulnerability t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e57d1dafe9b0786d2ab0cabccd8a7a9a
https://doi.org/10.1101/2021.09.30.21264351

Physical and Mental Health Services in Opioid Treatment Programs.

Autor: Shuey B; Center for Research On Healthcare, Division of General Internal Medicine, University of Pittsburgh, University of Pittsburgh Medical Center, 200 Meyran Ave, Pittsburgh, PA, 15213, USA. bryant.shuey@pitt.edu., Joudrey PJ; Center for Research On Healthcare, Division of General Internal Medicine, University of Pittsburgh, University of Pittsburgh Medical Center, 200 Meyran Ave, Pittsburgh, PA, 15213, USA., Anderson TS; Center for Research On Healthcare, Division of General Internal Medicine, University of Pittsburgh, University of Pittsburgh Medical Center, 200 Meyran Ave, Pittsburgh, PA, 15213, USA., Park TW; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA., Liebschutz JM; Center for Research On Healthcare, Division of General Internal Medicine, University of Pittsburgh, University of Pittsburgh Medical Center, 200 Meyran Ave, Pittsburgh, PA, 15213, USA.

Publikováno v: Journal of general internal medicine [J Gen Intern Med] 2024 Oct 02. Date of Electronic Publication: 2024 Oct 02.

Implementing a pharmacist-integrated collaborative model of medication treatment for opioid use disorder in primary care: study design and methodological considerations.

Autor: McLeman B; Northeast Node, NIDA Drug Abuse Treatment Clinical Trials Network, Hanover, NH, USA. Bethany.m.mcleman@dartmouth.edu.; Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College, Hanover, NH, USA. Bethany.m.mcleman@dartmouth.edu., Gauthier P; Northeast Node, NIDA Drug Abuse Treatment Clinical Trials Network, Hanover, NH, USA.; Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College, Hanover, NH, USA., Lester LS; Northeast Node, NIDA Drug Abuse Treatment Clinical Trials Network, Hanover, NH, USA.; Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College, Hanover, NH, USA., Homsted F; FQHC 340B Compliance, Lebanon, TN, USA., Gardner V 3rd; Northeast Node, NIDA Drug Abuse Treatment Clinical Trials Network, Hanover, NH, USA., Moore SK; Northeast Node, NIDA Drug Abuse Treatment Clinical Trials Network, Hanover, NH, USA.; Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College, Hanover, NH, USA., Joudrey PJ; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Saldana L; Lighthouse Institute, Chestnut Health Systems, Eugene, OR, USA., Cochran G; University of Utah, Salt Lake City, UT, USA.; Greater Intermountain Node, NIDA Drug Abuse Treatment Clinical Trials Network, Salt Lake City, UT, USA., Harris JP; The Emmes Company, LLC, Rockville, MD, USA., Hefner K; The Emmes Company, LLC, Rockville, MD, USA., Chongsi E; The Emmes Company, LLC, Rockville, MD, USA., Kramer K; The Emmes Company, LLC, Rockville, MD, USA., Vena A; The Emmes Company, LLC, Rockville, MD, USA., Ottesen RA; The Emmes Company, LLC, Rockville, MD, USA., Gallant T; Northeast Node, NIDA Drug Abuse Treatment Clinical Trials Network, Hanover, NH, USA.; Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College, Hanover, NH, USA., Boggis JS; Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College, Hanover, NH, USA., Rao D; Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College, Hanover, NH, USA., Page M; Community Health Care, Tacoma, WA, USA., Cox N; University of Utah College of Pharmacy, Salt Lake City, UT, USA., Iandiorio M; University of New Mexico School of Medicine, Albuquerque, NM, USA., Ambaah E; Harbor Care Health & Wellness, Nashua, NH, USA., Ghitza U; National Institute on Drug Abuse, North Bethesda, MD, USA., Fiellin DA; New England Consortium Node, NIDA Drug Abuse Treatment Clinical Trials Network, New Haven, CT, USA.; Program in Addiction Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT, USA., Marsch LA; Northeast Node, NIDA Drug Abuse Treatment Clinical Trials Network, Hanover, NH, USA.; Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College, Hanover, NH, USA.

Publikováno v: Addiction science & clinical practice [Addict Sci Clin Pract] 2024 Mar 18; Vol. 19 (1), pp. 18. Date of Electronic Publication: 2024 Mar 18.

"As safe as possible": a qualitative study of opioid withdrawal and risk behavior among people who use illegal opioids.

Autor: Frank D; Department of Social and Behavioral Sciences, School of Global Public Health, New York University, New York, NY, 10003, USA. dfrank40@gmail.com.; Center for Drug Use and HIV/HCV Research, School of Global Public Health, New York University, New York, NY, 10003, USA. dfrank40@gmail.com.; Woodside, NY, 11377, USA. dfrank40@gmail.com., Elliott L; Department of Social and Behavioral Sciences, School of Global Public Health, New York University, New York, NY, 10003, USA.; Center for Drug Use and HIV/HCV Research, School of Global Public Health, New York University, New York, NY, 10003, USA., Cleland CM; Center for Drug Use and HIV/HCV Research, School of Global Public Health, New York University, New York, NY, 10003, USA.; Department of Population Health, Grossman School of Medicine, New York University, New York, NY, 10003, USA., Walters SM; Center for Drug Use and HIV/HCV Research, School of Global Public Health, New York University, New York, NY, 10003, USA.; Department of Epidemiology, School of Global Public Health, New York University, New York, NY, 10003, USA., Joudrey PJ; Division of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, 15213, USA., Russell DM; Department of Family and Community Medicine, University of Arizona, Tucson, AZ, 85711, USA.; Harm Reduction Research Lab, Department of Family and Community Medicine, College of Medicine, University of Arizona, Tucson, AZ, 85711, USA., Meyerson BE; Harm Reduction Research Lab, Department of Family and Community Medicine, College of Medicine, University of Arizona, Tucson, AZ, 85711, USA., Bennett AS; Department of Social and Behavioral Sciences, School of Global Public Health, New York University, New York, NY, 10003, USA.; Center for Drug Use and HIV/HCV Research, School of Global Public Health, New York University, New York, NY, 10003, USA.; Center for Anti-Racism, Social Justice, and Public Health, 708 Broadway, 9th floor, New York, NY, 10003, USA.

Publikováno v: Harm reduction journal [Harm Reduct J] 2023 Oct 27; Vol. 20 (1), pp. 158. Date of Electronic Publication: 2023 Oct 27.

Drive Time to Addiction Treatment Facilities Providing Contingency Management across Rural and Urban Census Tracts in 6 US States.

Autor: Joudrey PJ; From the Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA (PJJ); Office of Ambulatory Care and Population Health, New York City Health and Hospitals Corporation, New York, NY (KC); Division of General Internal Medicine and Clinical Innovation, New York University Grossman School of Medicine, New York, NY (KC); Fair Haven Community Health Care, New Haven, CT (BJO); Yale Program in Addiction Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT (BJO, EM, DAF); Department of Emergency Medicine, Yale School of Medicine, New Haven, CT (DAF); Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (DAF)., Chen K, Oldfield BJ, Biegacki E, Fiellin DA

Publikováno v: Journal of addiction medicine [J Addict Med] 2023 Sep-Oct 01; Vol. 17 (5), pp. 615-617. Date of Electronic Publication: 2023 Apr 21.